| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2010-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1c8851e299c7404db4681c5f0e511c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d65ab5965d50fa1a181fb8170791f57a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e036409ae5d737f5a9ae74b19373ec77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef09afc3b680bb7e3a5429ab2e1fbaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e10996feb1db1241bcb5fa2ea287e6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa451c5a0e2d16ed0dc2ca4e8716de7d |
| publicationDate |
2012-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120014941-A |
| titleOfInvention |
Antibodies to Human CN1 and Uses thereof |
| abstract |
The present invention transforms a mammalian host cell with a nucleic acid vector encoding a CCN1 or a CCN1 domain thereof (CCN1 fusion protein) fused to a mammalian cell transmembrane domain at the C-terminus, and fusion of the CCN1 or CCN1 domain in the host cell. A method of recombinantly expressing a mammalian cell membrane-bound human CCN1 or a CCN1 domain thereof in a mammalian cell, characterized by expressing the protein and recovering the membrane-bound CCN1 or CCN1 domain thereof. The invention also relates to the use of said membrane-bound CCN1 and domains for the production of antibodies. Antibodies against human CCN1 are useful for the treatment of diseases. |
| priorityDate |
2009-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |